During his tenure at Immune Pharmaceuticals, Inc., Elliot Maza led significant capital-raising initiatives that secured more than $25 million from institutional investors. These efforts helped strengthen the company’s financial position and supported its continued operations and growth. To know more about him visit his official site http://elliotmaza.com/